Comparison Guide | Updated January 2025

GLP-1 Medications Compared Semaglutide vs Tirzepatide vs Retatrutide

A comprehensive, evidence-based comparison of GLP-1 weight loss medications to help you understand your options and make an informed decision with your healthcare provider.

Medical Disclaimer

This comparison is for educational purposes only. Medication selection should be made with a qualified healthcare provider based on your individual health profile.

At a Glance

Semaglutide

FDA Approved

GLP-1 Receptor Agonist

Avg Weight Loss: 15-17%
Dosing: Weekly injection or daily oral
Cost: $900-1,500/month

Brands: Ozempic, Wegovy, Rybelsus

Tirzepatide

FDA Approved

Dual GLP-1/GIP Agonist

Avg Weight Loss: 20-22%
Dosing: Weekly injection
Cost: $1,000-1,500/month

Brands: Mounjaro, Zepbound

Retatrutide

In Development

Triple GLP-1/GIP/Glucagon Agonist

Avg Weight Loss: 24% (Phase 2)
Dosing: Weekly injection (expected)
Cost: TBD

Brands: In Development

Detailed Comparison

Feature Semaglutide Tirzepatide Retatrutide
Mechanism GLP-1 only GLP-1 + GIP GLP-1 + GIP + Glucagon
FDA Status Approved Approved Phase 3
Weight Loss (Trials) 15-17% 20-22% ~24%
Administration Weekly SC or daily oral Weekly SC Weekly SC (expected)
Max Dose 2.4mg (Wegovy) 15mg 12mg (Phase 2)
Titration Period 16-20 weeks 16-20 weeks TBD
Monthly Cost $900-1,500 $1,000-1,500 TBD

Side Effects Comparison

While side effect profiles are similar across GLP-1 medications, frequency and severity can vary. The data below is from pivotal clinical trials.

Side Effect Semaglutide Tirzepatide Notes
Nausea 44% (STEP 1) 31% (SURMOUNT-1) Usually resolves in 4-8 weeks
Vomiting 24% 12% More common during titration
Diarrhea 30% 23% Dietary adjustments help
Constipation 24% 17% Increase fiber/water intake
Injection site reactions 3% 7% Rotate injection sites

Key Takeaways

  • Side effects typically decrease with slow, careful dose titration
  • Most patients find GI effects manageable and temporary
  • Discontinuation rate due to GI issues: approximately 5-7%

Efficacy: What the Research Shows

Multiple large-scale clinical trials have established the weight loss efficacy of GLP-1 medications. Here's what the pivotal studies show:

Semaglutide STEP Trial Program

STEP 1

14.9%

mean weight loss at 68 weeks (N=1,961)

STEP 2 (Type 2 Diabetes)

9.6%

weight loss in diabetic patients

STEP 3 (Behavioral Therapy)

16.0%

with intensive behavioral intervention

STEP 5 (Long-term)

Maintained

weight loss sustained at 2 years

Tirzepatide SURMOUNT Trial Program

SURMOUNT-1

20.9%

mean weight loss at 72 weeks (15mg dose)

SURMOUNT-2 (Type 2 Diabetes)

14.7%

weight loss in diabetic patients

SURMOUNT-3 (Lifestyle)

21.4%

with intensive lifestyle intervention

Achievement Rate

Higher

vs semaglutide for >20% weight loss

Retatrutide Phase 2 Data & TRIUMPH Program

Phase 2 Results

24.2%

weight loss at 48 weeks (highest dose)

Phase 3 Status

Ongoing

TRIUMPH trials in progress

Expected FDA Approval

2025-2026

pending Phase 3 completion

Note: Trial results represent mean weight loss. Individual results vary based on adherence, lifestyle factors, baseline characteristics, and other variables. Consult with your healthcare provider to understand expected outcomes for your specific situation.

Cost & Insurance Coverage

GLP-1 medication costs vary significantly based on insurance coverage, manufacturer programs, and chosen alternatives. Here's what you need to know in 2025:

List Prices (2025)

Wegovy (Semaglutide)

~$1,350

per month

Zepbound (Tirzepatide)

~$1,060

per month

Ozempic (Diabetes)

~$935

per month

Insurance Coverage

Coverage Varies Significantly

Plan-specific policies differ widely. Check your specific plan's formulary.

Prior Authorization Required

Most plans require pre-approval and documentation of medical necessity.

Typical Requirements

BMI ≥30 or BMI ≥27 with weight-related comorbidity (diabetes, hypertension, etc.)

Exclusions Common

Some plans explicitly exclude weight loss medications from coverage.

Savings Options

Manufacturer Savings Cards

Available for commercially insured patients (not Medicare/Medicaid).

  • • Wegovy Savings Offer: May reduce copay significantly
  • • Zepbound Savings Card: Check eligibility on manufacturer site

Patient Assistance Programs

Income-qualified programs from manufacturers.

  • • Novo Nordisk Patient Assistance: For uninsured/underinsured
  • • Lilly Cares: Income-based eligibility for tirzepatide

Compounded Alternatives

Cost: Typically $200-400/month from compounding pharmacies

Important Warning: Compounded versions are NOT FDA-approved. Quality and potency can vary significantly between pharmacies.

Safety Note: If considering compounded alternatives, only use licensed 503B outsourcing facilities. The FDA has issued warnings about contamination and dosing errors in some compounded GLP-1 products.

Last updated: January 2025. Prices and coverage policies change frequently. Verify current costs and coverage with your insurance provider and pharmacy.

Which GLP-1 Medication Is Right for You?

Consider Semaglutide If:

  • You want the longest track record of safety data
  • You prefer an oral option (Rybelsus)
  • Your insurance covers Ozempic or Wegovy

Consider Tirzepatide If:

  • Maximizing weight loss is your primary goal
  • You have type 2 diabetes with significant insulin resistance
  • You did not achieve goals with semaglutide

Frequently Asked Questions

Which GLP-1 medication is most effective for weight loss?
Based on clinical trials, tirzepatide (Mounjaro/Zepbound) shows the highest average weight loss at 20-22%, followed by semaglutide (Wegovy) at 15-17%. Retatrutide, still in development, has shown up to 24% in Phase 2 trials.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but Wegovy is FDA-approved for weight loss (chronic weight management) while Ozempic is approved for type 2 diabetes. Wegovy also comes in higher doses (2.4mg vs 2mg max for Ozempic).
Can I switch from semaglutide to tirzepatide?
Yes, switching is possible under medical supervision. Your provider will typically start you at the lowest tirzepatide dose and titrate up, regardless of your previous semaglutide dose. The transition should be managed carefully.
Which GLP-1 has fewer side effects?
Side effect profiles are similar across GLP-1 medications, with nausea, vomiting, and GI symptoms being most common. Some patients tolerate one medication better than others. Slow titration helps minimize side effects for all options.
Are compounded semaglutide or tirzepatide safe?
Compounded versions are not FDA-approved and quality can vary by pharmacy. The FDA has issued warnings about some compounded GLP-1 products. If using compounded versions, ensure they come from a licensed 503B facility.

Related Comparisons

Semaglutide vs Tirzepatide

Detailed head-to-head comparison with clinical trial data.

Complete Peptide Therapy Guide

Everything you need to know about peptide treatments.

Ready to Start GLP-1 Treatment?

Find verified clinics offering semaglutide, tirzepatide, and other GLP-1 medications near you.

Find Weight Loss Clinics